(Q79894968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Imatinib mesylate does not impair the immunogenicity of human myeloid blood dendritic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

4

Bornhäuser M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

5

Platzbecker U

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Wehner R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Wendisch M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Schäkel K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Mohr B

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Temme A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bachmann M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Rieber EP

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Schmitz M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

13 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1629-1632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16838025%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404315

26 December 2019

exact match

0 references

cites work

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of imatinib mesylate: implication for vaccination regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021

Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404315

7 January 2021